22.02.2024 - AUSTIN, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) - Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced . Seite 1